15 April 2015
Karus Therapeutics presenting at Sachs Immuno-oncology: BD&L and Investment Forum
Karus Therapeutics, a leader in the development of innovative medicines for the treatment of cancer and inflammatory disease, has announced that it will be presenting at Sachs Immuno-oncology: BD&L and Investment Forum, Chicago, USA, 29th May 2015.
Stephen Shuttleworth, Karus’s CSO, will present and CEO Simon Kerry will also be attending the conference.
For more information on Karus’s presentations or for media enquiries, please contact email@example.com.